Eli Lilly
How I knew when to start backing Novo Nordisk’s biggest rival instead
The Danish firm’s complacency is its undoing in the weight-loss drug war
Eli Lilly to invest US$1 billion in India contract manufacturing
The investment plan comes days after US President Donald Trump announced a 100% tariff on imported branded or patented drugs
Trump pressures 17 pharma CEOs to cut US drug prices
[WASHINGTON] President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White...
Lilly to boost obesity drug supply with US$3 billion expansion
ELI Lilly is spending another US$3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs.
Eli Lilly gets nod to launch blockbuster weight-loss drug in Hong Kong
ELI Lilly expects to start selling its highly popular weight-loss drug in Hong Kong as early as the end of this year, potentially making it the first of its kind to become available in the China regio...
Eli Lilly shells out US$4.5 billion for new drug development plant
It expects the facility to streamline manufacturing processes and increase capacity for clinical trial medicines
Lilly's weight-loss drug cuts diabetes risk in overweight patients
Eli Lilly’s weight-loss drug, Zepbound, drastically cut the risk of developing type 2 diabetes in overweight or obese pre-diabetic adults after three years of weekly injections, the drugmaker said on ...
Lilly agrees to buy US drugmaker Morphic in US$3.2 billion deal
ELI Lilly & Co agreed to buy US gut-drug maker Morphic Holding for about US$3.2 billion, ploughing some of the proceeds from obesity blockbuster Zepbound into its experimental pipeline.
Cosmetic Ozempic use under fire in Europe amid drug shortages
The EU regulator warned patients not to buy weight-loss drugs online without a prescription due to the risk of fake, dangerous products
Lilly invests over US$5 billion to boost weight-loss drug supply
The manufacturing investment is the largest in the company’s almost 150-year history
